Live Science on MSN
It matters what time of day you get cancer treatment, study suggests
Giving immunotherapy earlier in the day can significantly extend patients' survival, compared to giving treatment later in the day, a new study of lung cancer shows.
Ask a clinical question and tap into Healio AI's knowledge base. Lung cancer is generally the top cause of cancer-related death globally and in the United States (US). In the US in 2023, lung cancer ...
News-Medical.Net on MSN
Study finds a new protein target against KRAS-driven non-small cell lung cancer
In a study published in The Journal of Clinical Investigation, University of Michigan researchers found a new protein target ...
TipRanks on MSN
TROPION-Lung17: New phase III lung cancer trial adds medium-term upside potential for AstraZeneca and Daiichi Sankyo
TROPION-Lung17 Clinical Update: What Investors Should Watch in AstraZeneca and Daiichi Sankyo’s Next Lung Cancer Catalyst ...
AstraZeneca’s LATIFY phase 3 trial evaluating ceralasertib in combination with Imfinzi did not meet its primary endpoint of overall survival in ...
Small cell lung cancer (SCLC) is a fast-growing cancer that forms in the lung. It's one of two types of lung cancer. The other type is non-small cell lung cancer (NSCLC). SCLC is less common than ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback